FGFR1 forms an FRS2-dependent complex with mTOR to regulate smooth muscle marker gene expression

Biochemical and Biophysical Research Communications

Volumn 382, Issue 2, 2009, Pages 424-429

  Chen, Pei Yu ^a,b   Friesel, Robert ^a  

^a Maine Medical Center Research Institute   (United States)

^b UNIVERSITY OF MAINE   (United States)

Author keywords

FGFR1; FRS2; mTOR; Rapamycin; SM actin; VSMC

Indexed keywords

FIBROBLAST GROWTH FACTOR RECEPTOR 1; MAMMALIAN TARGET OF RAPAMYCIN INHIBITOR; PROTEIN;

ARTICLE; CARDIOVASCULAR DISEASE; CONTROLLED STUDY; DOWN REGULATION; EMBRYO; GENE EXPRESSION; HUMAN; HUMAN CELL; MARKER GENE; MUSCLE CELL; PRIORITY JOURNAL; PROTEIN FUNCTION; VASCULAR SMOOTH MUSCLE;

ACTINS; ADAPTOR PROTEINS, SIGNAL TRANSDUCING; ANIMALS; CATTLE; CELL LINE; GENE EXPRESSION REGULATION; GENETIC MARKERS; HUMANS; MEMBRANE PROTEINS; MUSCLE, SMOOTH, VASCULAR; PROTEIN KINASES; PROTO-ONCOGENE PROTEINS C-AKT; RATS; RECEPTOR, FIBROBLAST GROWTH FACTOR, TYPE 1; TOR SERINE-THREONINE KINASES;

EID: 63349099368     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2009.03.040     Document Type: Article

References (31)

1. Owens G.K. Regulation of differentiation of vascular smooth muscle cells. Physiol. Rev. 75 (1995) 487-517
2. Owens G.K. Molecular control of vascular smooth muscle cell differentiation and phenotypic plasticity. Novartis Found. Symp. 283 (2007) 174-191 discussion 191-173, 238-141.
3. Lindner V., and Reidy M.A. Proliferation of smooth muscle cells after vascular injury is inhibited by an antibody against basic fibroblast growth factor. Proc. Natl. Acad. Sci. USA 88 (1991) 3739-3743
4. Antoine M., Wirz W., Tag C.G., Mavituna M., Emans N., Korff T., Stoldt V., Gressner A.M., and Kiefer P. Expression pattern of fibroblast growth factors (FGFs), their receptors and antagonists in primary endothelial cells and vascular smooth muscle cells. Growth Factors 23 (2005) 87-95
5. Mohammadi M., Dikic I., Sorokin A., Burgess W.H., Jaye M., and Schlessinger J. Identification of six novel autophosphorylation sites on fibroblast growth factor receptor 1 and elucidation of their importance in receptor activation and signal transduction. Mol. Cell. Biol. 16 (1996) 977-989
6. Ong S.H., Hadari Y.R., Gotoh N., Guy G.R., Schlessinger J., and Lax I. Stimulation of phosphatidylinositol 3-kinase by fibroblast growth factor receptors is mediated by coordinated recruitment of multiple docking proteins. Proc. Natl. Acad. Sci. USA 98 (2001) 6074-6079
7. Kouhara H., Hadari Y.R., Spivak-Kroizman T., Schilling J., Bar-Sagi D., Lax I., and Schlessinger J. A lipid-anchored Grb2-binding protein that links FGF-receptor activation to the Ras/MAPK signaling pathway. Cell 89 (1997) 693-702
8. Lamothe B., Yamada M., Schaeper U., Birchmeier W., Lax I., and Schlessinger J. The docking protein Gab1 is an essential component of an indirect mechanism for fibroblast growth factor stimulation of the phosphatidylinositol 3-kinase/Akt antiapoptotic pathway. Mol. Cell. Biol. 24 (2004) 5657-5666
9. Firulli A.B., Han D., Kelly-Roloff L., Koteliansky V.E., Schwartz S.M., Olson E.N., and Miano J.M. A comparative molecular analysis of four rat smooth muscle cell lines. In Vitro Cell. Dev. Biol. Anim. 34 (1998) 217-226
10. Silverman E.S., Khachigian L.M., Santiago F.S., Williams A.J., Lindner V., and Collins T. Vascular smooth muscle cells express the transcriptional corepressor NAB2 in response to injury. Am. J. Pathol. 155 (1999) 1311-1317
11. Irie H.Y., Pearline R.V., Grueneberg D., Hsia M., Ravichandran P., Kothari N., Natesan S., and Brugge J.S. Distinct roles of Akt1 and Akt2 in regulating cell migration and epithelial-mesenchymal transition. J. Cell Biol. 171 (2005) 1023-1034
12. Schmidt M., Reiser P., Hills D., Gullick W.J., and Wels W. Expression of an oncogenic mutant EGF receptor markedly increases the sensitivity of cells to an EGF-receptor-specific antibody-toxin. Int. J. Cancer 75 (1998) 878-884
13. Kloth M.T., Laughlin K.K., Biscardi J.S., Boerner J.L., Parsons S.J., and Silva C.M. STAT5b, a mediator of synergism between c-Src and the epidermal growth factor receptor. J. Biol. Chem. 278 (2003) 1671-1679
14. Inoki K., Li Y., Xu T., and Guan K.L. Rheb GTPase is a direct target of TSC2 GAP activity and regulates mTOR signaling. Genes Dev. 17 (2003) 1829-1834
15. Yoshida T., Sinha S., Dandre F., Wamhoff B.R., Hoofnagle M.H., Kremer B.E., Wang D.Z., Olson E.N., and Owens G.K. Myocardin is a key regulator of CArG-dependent transcription of multiple smooth muscle marker genes. Circ. Res. 92 (2003) 856-864
16. Chiara F., Goumans M.J., Forsberg H., Ahgren A., Rasola A., Aspenstrom P., Wernstedt C., Hellberg C., Heldin C.H., and Heuchel R. A gain of function mutation in the activation loop of platelet-derived growth factor beta-receptor deregulates its kinase activity. J. Biol. Chem. 279 (2004) 42516-42527
17. Kim D.H., Sarbassov D.D., Ali S.M., King J.E., Latek R.R., Erdjument-Bromage H., Tempst P., and Sabatini D.M. MTOR interacts with raptor to form a nutrient-sensitive complex that signals to the cell growth machinery. Cell 110 (2002) 163-175
18. Kovalenko D., Yang X., Nadeau R.J., Harkins L.K., and Friesel R. Sef inhibits fibroblast growth factor signaling by inhibiting FGFR1 tyrosine phosphorylation and subsequent ERK activation. J. Biol. Chem. 278 (2003) 14087-14091
19. Mood K., Friesel R., and Daar I.O. SNT1/FRS2 mediates germinal vesicle breakdown induced by an activated FGF receptor1 in Xenopus oocytes. J. Biol. Chem. 277 (2002) 33196-33204
20. Neilson K.M., and Friesel R. Ligand-independent activation of fibroblast growth factor receptors by point mutations in the extracellular, transmembrane, and kinase domains. J. Biol. Chem. 271 (1996) 25049-25057
21. Pear W.S., Nolan G.P., Scott M.L., and Baltimore D. Production of high-titer helper-free retroviruses by transient transfection. Proc. Natl. Acad. Sci. USA 90 (1993) 8392-8396
22. Yang X., Webster J.B., Kovalenko D., Nadeau R.J., Zubanova O., Chen P.Y., and Friesel R. Sprouty genes are expressed in osteoblasts and inhibit fibroblast growth factor-mediated osteoblast responses. Calcif. Tissue Int. 78 (2006) 233-240
23. Martin K.A., Merenick B.L., Ding M., Fetalvero K.M., Rzucidlo E.M., Kozul C.D., Brown D.J., Chiu H.Y., Shyu M., Drapeau B.L., Wagner R.J., and Powell R.J. Rapamycin promotes vascular smooth muscle cell differentiation through insulin receptor substrate-1/phosphatidylinositol 3-kinase/Akt2 feedback signaling. J. Biol. Chem. 282 (2007) 36112-36120
24. Martin K.A., Rzucidlo E.M., Merenick B.L., Fingar D.C., Brown D.J., Wagner R.J., and Powell R.J. The mTOR/p70 S6K1 pathway regulates vascular smooth muscle cell differentiation. Am. J. Physiol. Cell Physiol. 286 (2004) C507-C517
25. Friesel R., and Maciag T. Fibroblast growth factor prototype release and fibroblast growth factor receptor signaling. Thromb. Haemost. 82 (1999) 748-754
26. Horowitz A., Tkachenko E., and Simons M. Fibroblast growth factor-specific modulation of cellular response by syndecan-4. J. Cell Biol. 157 (2002) 715-725
27. Friesel R., and Dawid I.B. CDNA cloning and developmental expression of fibroblast growth factor receptors from Xenopus laevis. Mol. Cell. Biol. 11 (1991) 2481-2488
28. Edinger A.L., Linardic C.M., Chiang G.G., Thompson C.B., and Abraham R.T. Differential effects of rapamycin on mammalian target of rapamycin signaling functions in mammalian cells. Cancer Res. 63 (2003) 8451-8460
29. Long X., Ortiz-Vega S., Lin Y., and Avruch J. Rheb binding to mammalian target of rapamycin (mTOR) is regulated by amino acid sufficiency. J. Biol. Chem. 280 (2005) 23433-23436
30. Alarcon C.M., Heitman J., and Cardenas M.E. Protein kinase activity and identification of a toxic effector domain of the target of rapamycin TOR proteins in yeast. Mol. Biol. Cell 10 (1999) 2531-2546
31. Chung J., Grammer T.C., Lemon K.P., Kazlauskas A., and Blenis J. PDGF- and insulin-dependent pp70S6k activation mediated by phosphatidylinositol-3-OH kinase. Nature 370 (1994) 71-75